Troutman Pepper recently advised Myonex in two acquisitions that strengthen the company’s position as a market leader in clinical trial supplies emphasizing flexibility and reliability for clients.
Acquisition of Saveway Compounding Pharmacy
In a purchase that will expand clinical trial services across the United States for both sponsors and patients, Myonex acquired SaveWay Compounding Pharmacy of Newark, Del. The pharmacy will operate as SaveWay Compounding Pharmacy, a Myonex company.
The Troutman Pepper team advising Myonex in this matter includes James Hipolit, Debbie Spranger, Joan Arnold, Jake McDonough, Ella Ogundare, Erin Whaley, Kevin Miserez, Emma Trivax, Stefanie Brennan, Brent Hoard, Natasha Halloran, Mike Jones, and Jessica Rothenberg.
Acquisition of Creapharm’s Clinical & Commercial Packaging and Bioservices Business
In March, Myonex announced its plans to acquire Creapharm Group’s Clinical Packaging & Distribution and Commercial Packaging business and bioservices, headquartered in Reims, France with additional locations in Bordeaux and Bailly-Romainvilliers, France, and Marietta, Georgia, USA. Subject to regulatory approvals, the strategic transaction will bring complementary strengths to the marketplace.
The Troutman Pepper team advising Myonex on the U.S. aspects of this matter includes James Hipolit, Debbie Spranger, and Joan Arnold.
Myonex is a leading global clinical trial supply company offering tailored solutions in central and local drug sourcing, packaging, labeling and ancillary equipment and supply to support each trial’s specific requirements and complexities.
Consistently recognized as a top-tier national practice, Troutman Pepper’s corporate attorneys regularly handle multimillion- and multibillion-dollar transactions. Core areas of service include capital markets transactions and other significant domestic and cross-border transactions, mergers and acquisitions, corporate governance, securities laws compliance, and corporate finance. The firm has particular expertise in the private equity and private fund services space, advising clients on matters from fund formation to investments and exit transactions.
Original source can be found here.